Skip to main content
Healthy Skeptic
search
Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts
  • search
Close Search

Commentary

 

Mar 03 2017

AHIP Response to Proposed 2018 Medicare Advantage Rates

By Kevin Roche Commentary No Comments
America's Health Insurance Plans sponsors a piece by actuarial firm Oliver Wyman regarding the proposed 2018 Medicare Advantage rates.
Read More
Mar 02 2017

Health Care Benefit Trends

By Kevin Roche Commentary No Comments
The Healthcare Trends Institute surveys 250 benefit managers to ascertain the state of health care benefits.
Read More
Mar 01 2017

Deductibles and Diabetes Care

By Kevin Roche Commentary No Comments
Having a low or a high deductible insurance plan is associated with a reduction in receipt of certain care by diabetes patients, but not with a change in outcomes.
Read More
Feb 28 2017

Prime Therapeutics Drug Trend Report

By Kevin Roche Commentary No Comments
Prime Therapeutics issues a press release about its drug trend for 2016.
Read More
Feb 27 2017

2016 Express Scripts Drug Trend Report

By Kevin Roche Commentary No Comments
Express Scripts offers up the first 2016 Drug Trend report, with forecasts for the future to boot.
Read More
Feb 24 2017

The Internet of Health Things???

By Kevin Roche Commentary No Comments
Accenture publishes a new survey on the internet of health things.
Read More
Feb 23 2017

Wage Level and Health Care Use

By Kevin Roche Commentary No Comments
A study in Health Affairs finds that lower-paid employees have different health care usage patterns and costs than do higher-paid ones.
Read More
Feb 22 2017

Does Bundled Payment Reimbursement Increase Volume?

By Kevin Roche Commentary No Comments
The Altarum Institute issues a report on the impact of bundled payment methods on volume of services.
Read More
Feb 21 2017

The Latest Health Spending Projections from the Office of the Actuary

By Kevin Roche Commentary No Comments
CMS' Office of the Actuary's new projections on health spending show above GDP growth as far as the eye can see.
Read More
Feb 17 2017

Pharmacogenomics and ER Use

By Kevin Roche Commentary No Comments
A study at the Public Library of Science finds that use of pharmacogenomics in managing drug regimens can help reduce readmissions and ER use.
Read More
  • « Previous
  • 1
  • …
  • 434
  • 435
  • 436
  • 437
  • 438
  • …
  • 641
  • Next »

✅ Receive notifications of new posts by email.

About this Blog

Kevin RocheThe Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.

Healthy Skeptic Podcast

Research

This is an outstanding report on total global drug spending and trends, with projections out to 2025.  It helps you understand this important area of health care, which does much...
June 1, 2021
The Office of the Actuary annual report on national health spending, covering 2018.
December 7, 2019
2019 Kaiser Family Foundation Employer Health Benefits Report
October 1, 2019
MedPAC 2019 Report to Congress
June 18, 2019

Headlines

Innovacer, which basically collects data on a patient from multiple sources and aggregates it, raised an astounding $275 million in new capital, supposedly at a valuation of almost $3.5 billion....
April 22, 2026
A company called Whoop raised a ridiculous $575 million in new capital at a supposed $10 billion valuation.  The press release was released on April 1, so I would like...
April 5, 2026
Big deals continue in health care financings.  eMed, which manages weight loss medications for employers, raises a hefty $200 million, giving it a valuation of $2 billion, which seems crazy....
March 31, 2026
Color Turquoise Health happy, as it raises $40 million in new capital to support an expansion of its business from price transparency to managing contracts for providers.  Unfortunately the price...
March 18, 2026

Tags

Access (89) ACO (165) Care Management (268) Chronic Disease (216) Comparative Effectiveness (81) Consumer Directed Health (71) Consumers (514) Devices (168) Disease Management (149) Drugs (605) EHRs (145) Elder Care (149) End-of-Life Care (97) FDA (85) Financings (1844) Genomics (80) Government (357) Health Care Costs (1428) Health Care Quality (616) Health Care Reform (1227) Health Insurance (1116) Health Insurance Exchange (162) HIT (478) HomeCare (76) Hospital (490) Hospital Readmissions (79) Legislation (78) M&A (1723) Malpractice (84) Meaningful Use (105) Medicaid (334) Medical Care (346) Medicare (607) Medicare Advantage (80) Mobile (89) Pay For Performance (92) Pharmaceutical (211) Physicians (569) Providers (252) Regulation (72) Repealing Reform (133) Telehealth (79) Telemedicine (325) Wellness and Prevention (316) Workplace (117)

About This Blog

The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry through Roche Consulting, LLC. Mr. Roche is available to assist health care companies through consulting arrangements and may be reached at khroche@healthy-skeptic.com. © Roche Consulting, LLC. Terms of Use.

Categories

  • Commentary
  • Headlines
  • Research

Useful Links

  • Congressional Budget Office
  • Health Affairs

RSS Feed

RSS feed

© 2026 Healthy Skeptic.

  • twitter
  • facebook
  • linkedin
Close Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts